Efficacy and Safety Study of Shenwu Capsule

Clinical trial NCT01451749 · COMPLETED

Trial details

NCT number: NCT01451749
Sponsor: North China Pharmaceutical Group Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2008-09-01
Primary completion: 2009-05-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.